Abera Bioscience
6.80 SEK
-8.72 %
Less than 1K followers
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-8.72 %
0.00 %
-0.73 %
+1.49 %
-7.48 %
+62.29 %
+24.77 %
-
-38.46 %
Abera Bioscience operates in biotechnology. The company specializes in the development of vaccines based on a proprietary and patented platform. The technology is mainly used in the development of new vaccines, with a focus on the main areas of pneumococci and immuno-oncology. The operations are located throughout the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Read moreMarket cap
126.68M SEK
Turnover
238.51K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25